FASLG and metabolic dysfunction-associated steatotic liver disease: Using enrichment analysis of phosphoproteomic datasets, Page et al. proposed C-C motif chemokine (CCL2) and tumor necrosis factor ligand superfamily member 6 (sFasL) as biomarkers in NAFLD pathogenesis [11].